Introduction
Bronchial asthma (here referred to as asthma) is chronic airway inflammation caused by many kinds of cells and inflammatory factors. Airway hyper-responsiveness, chronic inflammation, and airway remodeling are characteristic features of asthma [1, 2] . Epidemiological studies have found that the incidence and mortality of asthma are increasing year by year, but its pathogenesis is still unclear at present [3] . MicroRNAs (miRNAs) are non-encoding RNAs which are about 22 nucleotides in length. They regulate the expression of target genes by inhibiting their translation or causing mRNA degradation [4] . An increasing number of studies has found that many miRNAs may participate in asthma pathogenesis [5] . In an asthmatic mouse model, the upregulation of miR-221 and miR-485-3p may play an important role in the pathogenesis of asthma by downregulating the expression of Spre-2 [6] . Collison et al. demonstrated that the expression of miR-126 was upregulated in the airway wall tissues of asthmatic mice, and blocking miR-126 significantly reduced airway eosinophil cell infiltration [7] . Panganiban et al. showed that the expression of miR-1248 was upregulated in the serum of asthmatic patients, and it positively regulates the expression of interleukin (IL)-5, which is a key factor for chemotaxis, survival, and maturation of eosinophils [8] . In severe asthma, blood CD8+ T cells are activated at the same time, accompanied by reduced miR-146a/b and miR-28-5p expression [9] . In our previous study, we found that the expression of miR-20b in the lung tissues of asthmatic mice was significantly lower than that of normal mice [10] . In addition, miR-20b inhibited airway inflammation in asthmatic mice, but the mechanism remains unclear [11] . Since myeloid-derived suppressor cells (MDSCs) effectively inhibit airway inflammation in asthmatic mice [12] , in this study we analyzed the effect of miR-20b on MDSCs content in the lung tissue of asthmatic mice.
Material and methods

Mice
Female BALB/c mice (2-to 3-week-old) were purchased from the Center of Experimental Animals of Bengbu Medical College. This study was approved by the Animal Care and Ethics Committee of Bengbu Medical College.
Establishment of experimental asthma model and treatment
Female BALB/c mice were randomly divided into four groups, a normal control group (Control), an asthmatic group (Asthma), a miR-20b-mimic treatment group (MiR20b mimic) and a scrambled miR-20b treatment group (MiR-20b scrambled), with seven mice in each group. For all groups except the Control group, mice were sensitized by intraperitoneal injection with 200 μl liquid (including 50 μg of OVA and 2 mg of aluminum hydroxide) on days 0, 7, and 14. On day 21 from the start of the experiment, the mice were placed in an atomization inhalation box and were challenged with 5% OVA solution inhalation with nebulization for 30 min, continuously for 4 weeks. In addition, the MiR-20b mimic group was treated with 20 μg miR-20b mimics in 40 μl doses by nasal drip starting from the 20 th day, once every three days for a total of 10 doses. The MiR20b scrambled group received scrambled miR-20b instillation to replace the treatment with miR-20b mimics (Fig.1) .
Preparation of bronchoalveolar lavage fluid (BALF)
On day 49, the mice in each group were sacrificed and tracheal intubations were performed. Mice were lavaged 6 times with 0.8 ml PBS. The BALF obtained (in total about 4.8 ml) was centrifuged at 500 × g for 5 min and the supernatant was stored at -20°C for later use in an enzyme-linked immunosorbent assay (ELISA).
Oligonucleotides, siRNAs, and primers
MiR-20b mimics, scrambled miR-20b, CREB siRNA, and CREB control siRNA were obtained from Genepharma (Shanghai, China). The miRNA sequences used were as follows: miRNA-20b mimics, sense: 5'-CAA AGU GCU CAU AGU GCA GGU AG-3', antisense: 
Quantitative real-time PCR (qRT-PCR)
Total RNA was extracted using TRIZOL (Invitrogen). cDNA was synthesized with a TransScript First-strand cDNA Synthesis SuperMix kit from TransGen. The reaction mix included total RNA (500 ng), 1 μl anchored oligo (dT), 10 μl 2 × TS Reaction Mix, and 1 μl TransScript RT/RI Enzyme Mix (the anchored oligo (dT) was replaced with the RT primer corresponding to the target gene when 21 23 26  29  32  35  38  41  44  47 48 49 the miRNA cDNA first-strand was synthesized). The reaction conditions were 30 min at 42°C then 85°C for 5 min. Quantitative PCR (qPCR) was performed with the StepOnePlus System (ABI) using the TransStartTM EcoGreen qPCR SuperMix (TransGen). The amplification conditions were 94°C for 30 s, followed by 40 cycles of 94°C for 5 s, and 60°C for 30 s. U6 RNA or GAPDH were used as endogenous controls for miRNA or other mRNA levels. The relative gene expression was analyzed using the 2¯Δ ΔCT method.
FACS analysis
On day 49, the lung tissues from each group were obtained. Single-cell suspensions were prepared from these lung tissues and incubated with fluorescein-conjugated antibodies for 30 min at 4°C in the dark. The stained cells were analyzed using a flow cytometer (BD FACSCaliber).
ELISA
The amount of cytokines in the serum or the BALF was determined with commercial sandwich ELISA kits (CUSABIO) according to the manufacturer's instructions.
Western blot analysis
Briefly, RAW 264.7 cells were lysed with NP-40 lysis buffer with 1 mM PMSF. Cell lysates were separated by 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis and transferred to nitrocellulose membranes. The membranes were blocked with 5% BSA in TBST and probed with the respective antibodies. The blots were detected using enhanced chemiluminescence according to the manufacturer's protocol (Beyotime biotechnology).
Statistical analysis
Data are expressed as mean ± standard deviation. SPSS16.0 was used to perform single-factor analysis of variance for multiple groups. A P-value < 0.05 was considered statistically significant.
Results
MiR-20b suppresses Th2 cytokine production in the BALF of asthmatic mice
To understand the mechanism by which miR-20b inhibits allergic airway inflammation, we studied the effect of miR20b on the production of Th1/Th2-type cytokines in mouse BALF. The results are shown in Fig. 2 . Compared with the normal control group, the levels of the Th2-type cytokines IL-4 and IL-13 were significantly increased in the BALF of the asthmatic mice. However, the Th1-type cytokine IFN-γ was not significantly decreased in the asthmatic mice. The secretion of IL-13 and IL-4 was significantly decreased after treatment with miR-20b mimics in asthmatic mice (p < 0.01).
In contrast, the production of IL-10 in each group was not significantly different in this experimental system.
MiR-20b promotes the accumulation of CD11b+Ly6G+Ly6Clow MDSCs in asthmatic mice
Since MDSCs have significant immunosuppressive activity, their relationship with asthma has recently attracted attention. To discern whether the inhibitory effect of miR20b on airway inflammation involves MDSCs, the MDSC profiles in the lung tissues of mice in each group were assayed (Fig. 3) . The results showed that there was not a significant increase of MDSCs in the asthma group compared with the normal group. After treatment with miR20b mimics, the CD11b+Ly6G+Ly6C low MDSC ratio was significantly elevated in asthmatic mice (p < 0.05), while the increase in CD11b+Ly6C+Ly6G-MDSCs was not statistically significant. Treatment with miR-20b-scramble did not have a significant effect on the content of MDSCs in the lung tissues of asthmatic mice.
MiR-20b increases CCL2 and TGF-β in asthmatic mice
In this study, the CCL2 content in each group was detected, and the results are shown in Fig. 4A . There was not a significant difference in CCL2 concentration between the asthmatic group and the normal group, while CCL2 levels in BALF were significantly higher after asthmatic mice treatment with miR-20b mimics. Therefore, miR-20b induced the accumulation of MDSCs accompanied by an increase in CCL2 concentration in the lungs of asthmatic mice. Because TGF-β is an important effector molecule of MDSCs, the concentration of TGF-β in the BALF and serum of each group of mice was assayed (Fig. 4B, C) . As expected, relative to the other three groups, the concentration of TGF-β, whether in the serum or in the BALF, was increased in the miR-20b-mimic treatment group.
CREB regulates miR-20b expression
At present, there have been few studies on the regulation of miR-20b expression. We used two bioinformatics software packages, P-MATCH 1.0 (http://www.gene-regulation.com/cgi-bin/pub/programs/pmatch/bin/p-match. cgi) and AliBaba2 (http://www.gene-regulation.com/pub/ programs/alibaba2/index.html), to predict the transcription factors that might be involved in the regulation of miR-20b expression, in which the CREB score was higher. Thus, we attempted to verify whether CREB regulates the expression of miR-20b. The expression of miR-20b in RAW 264.7 cells transfected with CREB siRNA was analyzed by qRT-PCR analysis (Fig. 5A, B) . CREB siRNA decreased the miR-20b level to 0.375-fold of the control (p < 0.01). To confirm the activity of CREB siRNA, we examined the mRNA and protein level of CREB in RAW 264.7 cells after transfection. The level of CREB mRNA decreased by 66% after CREB siRNA transfection for 48 h (Fig. 5C ). The expression of the CREB protein was also decreased by 75% (Fig. 5D) . These results indicate that the expression of miR-20b is regulated by CREB upstream in RAW 264.7 cells.
Discussion
Myeloid-derived suppressor cells are a group of myeloid precursor cells which fail to differentiate into mature immune cells. Having prominent immunosuppressive activity, MDSCs can significantly inhibit the function of a variety of T cells [13, 14] . Myeloid-derived suppressor cells can be divided into different subsets based on their surface molecules. In humans, MDSCs can be subdivided into the CD11b+CD33+HLA-DR−CD14+ and CD11b+C-D15+HLA-DR−CD14− subgroups. In mice, MDSCs can be further subdivided into CD11b+Ly6G+Ly6C low and CD11b+Ly6C+Ly6G− subsets according to Ly-6C/G ex- [20] . Our previous study indicated that CCL2 signaling mediates the migration of MDSCs into the lung. In this study, we found that miR20b can induce an increase in CCL2 concentration in the lungs of asthmatic mice [12] . Therefore, miR-20b may induce the accumulation of MDSCs by upregulating CCL2 chemokines in the lungs of asthmatic mice. Once activated by inflammation-or tumor-driven factors, MDSCs can release a variety of biologically active mediators, including inducible nitric oxide synthase (iNOS), arginase 1, reactive oxygen species (ROS), IL-10, and transforming growth factor β (TGF-β) to inhibit the function of immune cells [21, 22] . Our preliminary results indicate that tumor-derived MDSCs inhibit the allergic Th2 response in a TGF-β-dependent manner. In this study, we also found that the elevation of MDSCs induced by miR-20b was accompanied by an increase in TGF-β in BALF and blood. Thus, miR-20b may inhibit airway inflammation in a TGF-β-dependent manner by inducing MDSCs in asthmatic mice.
Th1/Th2 cytokines play a key role in regulating airway inflammation in asthmatic mice [23] . It is noteworthy that the administration of miR-20b suppressed Th2 cytokines in the BALF of asthmatic mice in the current study. Recent studies have shown that miRNAs play an important role in regulating the balance of the Th1/Th2 immune response [24] . Lu et al. showed that lung eosinophil infiltration was decreased and the Th1-type cytokine IFN-γ was significantly increased when miR-21 was blocked in a murine asthma model. Meanwhile, DC with miR-21 deficiency increased the production of IL-12 after stimulation with LPS. miR-21-deficient mice had significantly increased Th1 delayed-type hypersensitiv- ity [25] . These studies emphasize that miR-21 mainly regulates Th1 response rather than the Th2 reaction. Meanwhile, Mohnle et al. showed that miR-146 phosphorylated STAT4 by targeting PKCε, thus resulting in Th1-cell differentiation [26] . However, our study showed that miR-20b inhibited the Th2-type response in asthmatic mice, but had no effect on Th1-type response. A study by Mattes et al. also showed that the function of Th2 cells was inhibited, and the symptoms of asthma were reduced, in mice with miR-126 ablation, and blocking miR-126 may lead to the increased expression of POU domain class 2 associating factor 1, which can negatively regulate the expression of the Th2-specific regulatory factor GATA3 [27] .
This study also demonstrated that the transcription factor CREB can regulate the expression of miR-20b at the upstream level. Since the pathogenesis of asthma is closely related to miRNAs, research on the regulation of miRNAs may shed light on new asthma treatments [28] . At present, research on the regulation of miRNA expression is relatively rare. Recent studies show that the CCCTC-binding factor (CTCF) can not only control the expression of miR-125b1 and miR-375, but can also adjust the level of the miR-290 cluster in tumor cells [29] . Chavali et al. Amplication Plot
